The myeloid immune compartment orchestrates adaptive immune cells44 and using our syngeneic orthotopic CRC mouse model, we have previously demonstrated that these cells, particularly CD8+ T cells lymphocytes, act as key effectors cells restricting MC38 tumor growth39. Here, CD8A is linked to neoplasm.